Белорусский научно-исследовательский институт эпидемиологии и микробиологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Белорусский научно-исследовательский институт эпидемиологии и микробиологииfiledCriticalБелорусский научно-исследовательский институт эпидемиологии и микробиологии
Priority to SU4494077/13ApriorityCriticalpatent/SU1565027A1/en
Application grantedgrantedCritical
Publication of SU1565027A1publicationCriticalpatent/SU1565027A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: virology. SUBSTANCE: agent used for inactivation of the West Nile virus is haloperidol. Proposed drug is used as antiviral preparation against viruses showing pathogenicity in human. EFFECT: increased effectiveness of agent.
SU4494077/13A1988-08-291988-08-29Inactivating agent of the west nile virus
SU1565027A1
(en)
Pharmaceutical composition for treatment of viral infections, method for preparation of composition, method for treatment or prophylaxis of aids in human
Pharmaceutical composition for prophylaxis and treatment of viral diseases, method of its preparing and use of bradykinin antagonist or its physiologically tolerant salt as agent for prophylaxis and treatment of viral diseases
METHOD FOR INHIBITING HUMAN IMMUNO DEFICIENCY VIRUS AND OTHER VIRUSES IN HUMAN BLOOD PLASMA WITH PRESERVATION OF FUNCTIONAL ACTIVITY OF BLOOD PLASMA PROTEINS